S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02%
Next Bullish Trade
Sign in
BSX

Boston Scientific Corporation NYQ · BSX

$44.03 -0.59 (-1.32%)
Pullback · -0.61σ Grade C
Mkt cap $65.4B
P/E 18.4
Day $43.76 – $45.25
52wk $42.20 – $94.75
Avg vol 20.9M
Beta 0.58
Div yld
Next earnings 2026-07-29

Quick read

Plain English

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.

BSX last traded at $44.03, down 1.3% on the day; that's in the lower part of its 52-week range ($42.20–$94.75). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.

The next scheduled earnings report (2026-07-29) is the biggest known catalyst on the calendar, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

below KC1 upper, -0.53 ATR from EMA21 — bearish engulfing

Long
score 9 · tech 9 / 80 · support 0 / 20
above KC1 lower, -0.53 ATR from EMA21 · no notable pattern
  • · Stochastic bull cross
  • · Counter-trend long in strong downtrend
How this grade was earned
total 9 pts
Cycle position 6
Momentum 3

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short C
score 29 · tech 29 / 80 · support 0 / 20
below KC1 upper, -0.53 ATR from EMA21 · bearish engulfing
  • · Bearish engulfing — body fully covers prior green bar
  • · Aligned with strong downtrend (strong tailwind)
How this grade was earned
total 29 pts
Cycle position 6
Candle signal 13
Market fit 10

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →
21 EMA +1 ATR +2 ATR −2 ATR
O H L C

Under the hood

On the latest daily bar, momentum sits mid-range (RSI 42), the trend is strong (ADX 27), and volume is about normal (0.8×). On the business side, revenue is growing 12% year over year and the business keeps about 14 cents of every sales dollar as free cash.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI
42
0–100 · <30 oversold
Trend strength · ADX
27
>25 = strong trend
Volume vs avg
0.77×
1× = average
Stretch from avg
-0.5 ATR
− below · + above
Zone touches
0
tests of this zone
Suggested hold
3–30
bars (≈ days)
Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Revenue growth
+11.6%
year over year
Free-cash-flow margin
14.0%
cash kept per $ of sales
Debt / equity
0.42
lower = less leveraged
P/E ratio
18.4
price ÷ yearly profit

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $42.29 (fair range $38–$43); today's price sits 4% above that estimate. The model's verdict is “Fair” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)
$42.29
Fair-value range
$37.77 – $43.02
Margin of safety
-4%
Verdict
Fair
Accounting quality Weak
  • ✓ Positive retained earnings
  • ✓ Gross margin 69% (pricing power)
  • ⚠ Debt exceeds cash
  • ⚠ Quick ratio 0.81 (fragile)

Price implies ~12% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

BSX is a $65.4 billion company, priced at 18× last year's earnings, and it moves more calmly than the market (beta 0.6); the stock is trading near the bottom of its 52-week range.

Mkt cap $65.4B
P/E ttm 18.4
Fwd P/E 11.9
Beta 0.58
Day range $43.76 – $45.25
52w range $42.20 – $94.75
Avg vol 20.9M
RSI(2) 51.1
ROE 14.7%
Net mgn 17.3%
FCF mgn 13.6%
Debt/Eq 0.42
Div yld
Sector Healthcare
Industry Medical Devices
Next earn 2026-07-29
52-week range · today's price
$42.20$94.75

More on BSX

Options idea

See more →
CALL $45 2026-08-21
$2.37
PUT $45 2026-08-21
$3.38

Earnings

See more →
Last reported
2026-04-22
EPS (act / est)
0.80 / 0.79
Surprise
+1.6%
Next report
2026-07-29

About

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced del…